Caryn Lerman: The intersection of Social Determinants of Health and Tumor Immunosuppression
Caryn Lerman, Director of USC Norris Comprehensive Cancer Center, shared on LinkedIn:
“Unlocking New Insights: The intersection of Social Determinants of Health and Tumor Immunosuppression. Breast cancer affects millions. Did you know that non-medical factors such as income, education, and access to healthcare can greatly affect breast cancer outcomes? Learn about pioneering research of Dr. Evanthia Roussos Torres and her team that is exploring how these factors influence the tumor microenvironment, with a particular focus on Hispanic and Latino communities.”
Dr. Caryn Lerman, Director of USC Norris Comprehensive Cancer Center and the H. Leslie and Elaine S. Hoffman Professor in Cancer Research, is renowned for her work in cancer prevention. Her approach merges neuroscience, pharmacology, genetics, and behavioral science. Notably, she generated the initial empirical data on genetic testing outcomes for cancer susceptibility. Lerman’s research sheds light on the genetic causes of cancer risk behaviors. Her studies led to the first prospective stratified pharmacogenomic trial for tobacco dependence, revolutionizing precision medicine in tobacco addiction treatment.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023